Enzo Biochem Fiscal Q2 Revenues Sink 26 Percent

Mar 11, 2019

|

NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Monday that its fiscal second quarter revenues fell 26 percent year over year, largely due to a 36 percent drop in its clinical services revenues.

For the three months ended Jan. 31, the diagnostics company said total revenues sank to $19.3 million from $26.2 million a year earlier.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Holden Thorp to Take Over at Science

Holden Thorp is to be the new editor-in-chief of Science and its related journals.

Fewer Fish in the River

A genetic analysis of salmon scales collected over the course of a century points to a sharp decline in the number of fish returning each year to river in British Columbia, CBC reports.

Ancient DNA Lab Head Suspended During Workplace Culture Review

Adelaide University has suspended the head of an ancient DNA lab as its investigation of workplace bullying continues, Australia's ABC News reports.

PNAS Studies Describe Adipocyte Subtypes, Plant Expressome Analysis, More

In PNAS this week: gene expression profiles of adipocyte subtypes, computational approach for improving plant expressome analysis, and more.

Menu